International Journal of Medical Therapeutics (IJMT-ONLINE) is dedicated to the dissemination of reliable and evolving evidence derived from clinical pharmacology and other therapeutic approaches to scientists and clinicians working in a variety of research, academic, and clinical practice settings. IJMT-ONLINE is committed to the harmonization and globalization of drug development.
IJMT-ONLINE strives to achieve its mission by providing peer-reviewed, rapid publication of recent developments in drug therapies, as well as in-depth review articles on specific agents, treatment strategies, and disease states. Most articles are available online within 15 business days after acceptance.
Published articles range from pivotal studies exploring the therapuetic usage of new chemical entities in large, multicenter trials to those exploring repurposing of market agents. Additionally, reports that assess drug safety and tolerability in all phases of developments; new routes of administration and new formulations; pharmacokinetic, bioavailability, bioequivalence and biosimilarity; and changes in practice guidelines and standards, are all of interest for publication.
IJMT-ONLINE also understands the importance of strengthening the body of evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials. Beyond the clinic, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a double-blind review process.